Jeske Smink

Jeske Smink has an extensive background in research and development, focusing on bone biology and cell-based therapies. Jeske has held various positions in different companies, including Silence Therapeutics plc, ProBioGen AG, and CO.DON AG. Jeske's expertise lies in drug substance development, CMC project management, scientific affairs, and molecular mechanisms in bone biology. Jeske has a BSc and MSc in Biology from Utrecht University.